A rthropod-borne flaviviruses (FVs) are a growing world-wide health threat whose incidence and range are increasing. The pathogenicity and cytopathicity of these single-stranded RNA viruses are influenced by viral subgenomic non-protein-coding RNAs (sfRNAs) that the viruses produce to high levels during infection. To generate sfRNAs the virus co-opts the action of the abundant cellular exonuclease Xrn1, which is part of the cell's normal RNA turnover machinery. This exploitation of the cellular machinery is enabled by discrete, highly structured, Xrn1-resistant RNA elements (xrRNAs) in the 3 0 UTR that interact with Xrn1 to halt processive 5 0 to 3 0 decay of the viral genomic RNA. We recently solved the crystal structure of a functional xrRNA, revealing a novel fold that provides a mechanistic model for Xrn1 resistance. Continued analysis and interpretation of the structure reveals that the tertiary contacts that knit the xrRNA fold together are shared by a wide variety of arthropod-borne FVs, conferring robust Xrn1 resistance in all tested. However, there is some variability in the structures that correlates with unexplained patterns in the viral 3 0 UTRs. Finally, examination of these structures and their behavior in the context of viral infection leads to a new hypothesis linking RNA tertiary structure, overall 3
Introduction
Arthropod-borne flaviviruses (FVs) are single-stranded positive-sense RNA viruses that include Dengue, Yellow Fever, Japanese Encephalitis, West Nile, Murray Valley Encephalitis, Zika, and many others. The range of their arthropod vectors continues to increase due to human trade and climate change, making them growing worldwide health threats. [1] [2] [3] [4] [5] The genomes of these FVs comprise a singlestranded RNA molecule containing one open reading frame that is flanked by structured 5 0 and 3 0 untranslated regions (UTRs) important for genome circularization and processes including viral replication, packaging, and translation of the viral genome. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Several decades ago, it was recognized that in addition to the full-length positive-sense genomic RNA, other smaller viral RNA species accumulate to high levels during FV infection. [17] [18] [19] These subgenomic FV RNAs (sfRNAs) were subsequently linked to viral pathogenesis in fetal mice and cytopathicity in cell culture, thus sfRNAs are directly associated with disease. 19 sfRNAs in diverse viruses have been reported to alter mRNA degradation patterns, 20 affect miRNA-dependent pathways 21 , disrupt the interferon-induced antiviral response, [22] [23] [24] [25] and interact with the viral replication complex. 26 For a more comprehensive overview of sfRNA function during infection, the reader is directed to recent reviews. [27] [28] [29] The mechanism by which sfRNAs are produced during viral infection is an example of how viruses can co-opt cellular pathways using structured RNAs. In a seminal publication, Pijlman et al. discovered that arthropod-borne FVs exploit cellular exonuclease Xrn1 19 , an enzyme that is an important component of the cell's RNA turnover machinery.
During normal RNA turnover, mRNAs destined for degradation are decapped, leaving a 5 0 monophosphate that is the substrate for Xrn1, which then degrades the RNA processively in a 5 0 to 3 0 direction. [30] [31] [32] During sfRNA production, Xrn1 loads on a subset of viral genomic RNAs that presumably have either been decapped or cleaved internally to leave a 5 0 monophosphate, then degrades the RNA from the 5 0 to the 3 0 end (Fig. 1A) .
When Xrn1 reaches the 3 0 UTR of the viral genomic RNA it encounters structured RNA elements called Xrn1-resistant RNAs (xrRNAs). [33] [34] [35] Xrn1 cannot proceed through these xrRNAs, thus the RNA located 3 0 of each structure is protected from degradation, resulting in sfRNA. Often more than one xrRNA element exists in the 3 0 UTR of a FV, giving rise to a set of sfRNAs of different lengths ( Fig. 1 B & C) . 19, 27, 28, [33] [34] [35] [36] Recently, more divergent members of the Flaviviridae, including hepatitis C virus, have been shown to stall Xrn1 and alter the stability of the host cell's mRNA. 37 However, the degree of Xrn1 resistance is much less than in the arthropod-borne FVs and the RNA elements responsible do not appear to be structurally related.
How can an RNA element less than 100 nucleotides long halt an exoribonuclease capable of degrading large structured RNAs such as rRNAs? To help answer this question, we recently solved the structure of a functional xrRNA from the Murray Valley Encephalitis Virus (MVE). 36 This structure revealed an RNA fold centered on a 3-way junction that forms a novel ring-like feature through which the 5 0 end of the xrRNA passes ( Fig. 2A) . The fold is reminiscent of a knot, although pulling on the 5 0 and 3 0 ends would fully unwind it. The structure suggests a mechanism for Xrn1 resistance: when Xrn1 encounters an xrRNA, the ring-like feature braces over the entrance to the active site. This may create a mechanical unfolding problem that blocks enzyme progression from the 5 0 side or may prevent the elements in Xrn1 that are thought to unwind RNA from accessing the next set of base pairs. 36 This model would explain how the xrRNA structure can prevent Xrn1 from progressing through from the 5 0 direction, but allow the viral RNA-dependent RNA polymerase (and reverse transcriptase used in experiments 35, 36 ) to progress through from the 3 0 direction. Here, we present additional analysis and a discussion of the high-resolution crystal structure of the MVE xrRNA with the goal of gaining greater insight into how this structure relates to other FV xrRNAs and to viral infection. Our analysis reveals that certain features observed in this structure are very likely present in xrRNAs in diverse arthropod-borne FV 3 0 UTRs, and these features may reveal a mechanism for how xrRNAs properly fold. Also, we find that xrRNA structures in FVs display unexpected patterns in the placement and characteristics of the xrRNAs, motivating more experiments. Together this invites a new hypothesis linking RNA tertiary structure modulation, overall 3 0 Figure 1 . xrRNAs and sfRNA production. (A) Diagram of the mechanism of sfRNA production by partial degradation of the viral genomic RNA by Xrn1 (green). Upon reaching the 3 0 UTR, Xrn1 encounters xrRNA structures that halt enzyme progression, leading to a set of sfRNAs. (B) Northern blot analysis of the sfRNAs produced during WNV KUN infection, with sizes of RNA (number of nucleotides) shown. Diagram and blot are adapted from a previous publication. 35 (C) Cartoon diagram of the secondary structure of a "generic" FV 3 0 UTR. The two stem-loop structures (SLs) and two dumbbell (DB) structures are shown. Different FVs have variations on this architecture, with some having only one SL or DB, and some with additional sequence or structure between these elements. Solid red arrows denote robust Xrn1 halt sites and the xrRNAs that correspond to those halt sites are boxed. Open red arrows denote possible halt sites that are less well characterized.
UTR architecture, sfRNA production, and host adaptation.
Two tertiary interactions form an unexpected structure and suggest a folding pathway
The MVE xrRNA structure reveals two long-range tertiary interactions important for stabilizing the active conformation, 36 which may be defining characteristics of an xrRNA. The first is a pseudoknot interaction between the L3 loop and the singlestranded S4 segment (Fig. 2, yellow) . This interaction was predicted based on phylogenetic co-variation, functional studies, and chemical probing. 19, [33] [34] [35] Interestingly, in the crystal structure the sequences predicted to form this pseudoknot are not base-paired, rather they are located near each other and appear "poised" to pair. In the crystal, these nucleotides are involved in crystal contacts and thus it is not clear whether this unpaired conformation is due to crystallization or might reflect a functionally important state. As discussed later, the possible labile nature of this pseudoknot may have implications for the xrRNA folding pathway and for modulating function. The second long-range tertiary interaction was unexpected, comprising a base triple and base pairs formed between the 5 0 end of the xrRNA (S1) and nucleotides within the RNA 3-way junction (S3) ( Fig. 2A , red, cyan). This functionally important interaction is what positions the 5 0 end within the ring-like structure; the base pairs in the S1-S3 interaction can be considered to comprise a second pseudoknot.
The xrRNA structure presents an interesting folding problem: in the context of the full viral genomic RNA, how does the 5 0 end thread through the ring-like element? Consider a thought experiment in which the L3-S4 pseudoknot formed and closed the ring before the S1-S3 interaction between the 5 0 end and the 3-way junction formed. In such a scenario, the entire viral genomic RNA, starting at the 5 0 end, would have to thread through the closed ring (a seemingly impossible task). Fortuitously, the fact that within the crystal structure the L3-S4 pseudoknot was unpaired, yet the ring is largely formed and the 5 0 end is docked, provides a hypothesis for how this scenario is avoided (Fig. 3A  & B) . Briefly, until the 5 0 nucleotides interact with those in the 3-way junction, the junction is unstructured and the ring is open. Once these interactions form, the junction folds, causing helices P3 and P1 to swing into position and form the ring around the 5 0 end. This positions the L3 and S4 bases to form the pseudoknot, "latching" the ring shut and fully stabilizing the Xrn1-resistant conformation.
Is there evidence for this model? In addition to the crystal structure, chemical probing experiments with an xrRNA from Dengue Virus 2 (DENV2) suggest the L3-S4 pseudoknot is conformationally dynamic or transiently formed. 35 The importance of this pseudoknot for Xrn1 resistance also appears to vary between xrRNAs, suggesting that the specific characteristics of this pseudoknot may modulate the robustness of Xrn1 resistance for different xrRNAs. 35, 36 These ideas, suggested by the structure, remain largely untested, but application of modern biophysical methods linked with virology promises to give additional insight.
How conserved is the xrRNA structure and ability to robustly resist Xrn1?
Our previously published analysis of Xrn1 resistance by elements of the DENV2 3 0 UTR showed that 2 xrRNAs in this UTR resist Xrn1 degradation in a reconstituted resistance assay and also share similar secondary structures. 35 To extend these findings we probed three other xrRNAs. This included the first xrRNA from MVE (MVExrRNA1) (the crystal structure was of the second MVE xrRNA, MVExrRNA2), an upstream xrRNA from West Nile Virus (WNVxrRNA1) and the single identified xrRNA from Yellow Fever Virus (YFxrRNA). Chemical probing was conducted as previously described. 35 All displayed similar probing patterns suggesting that despite variation in primary sequence they form similar secondary structures (Fig. 4A) , consistent with previous predictions. 19, 33 To determine if these xrRNAs are all capable of quantitatively resisting Xrn1, we employed a fluorescence-monitored time-resolved assay that was previously described. 35 All of these xrRNAs resisted Xrn1 over more than an 0 end (S1) and nucleotides in the 3-way junction (S3), and cyan indicates the base triple that forms between a U in S1 and a base pair in P1. Yellow indicates the pseudoknot interaction between L3 and S4 that was previously predicted. Right: The secondary structure redrawn to more accurately depict the structure and these tertiary interactions.
hour (Fig. 4B) . Although it was previously shown qualitatively that these RNAs could resist Xrn1 36 , this result reveals the ability to do so quantitatively when challenged over long time periods in vitro. This is interesting, because examination of the pattern of sfRNAs formed during infection suggests that xrRNAs are not completely quantitative in cells and may have different Xrn1-halting efficiencies; clearly, this requires further examination. Together, these data add strong credence to the idea that the 3-dimensional folded structures of these RNAs are similar and thus the structural basis of Xrn1 resistance is conserved across diverse FVs. This invites further exploration of differences in the function of these elements in vivo vs. in vitro.
Evidence for conserved tertiary structures and unexpected patterns in diverse FV 3 0 UTRs The three-dimensional xrRNA structure revealed two critical tertiary interactions; if the hypothesis that this structural architecture is used by a wide range of xrRNAs from diverse FVs is correct, we should be able to predict these tertiary interactions in a wide range of FV 3 0 UTRs. To this end, we examined a large set of mosquito-borne FV 3 0 UTRs to determine if they contained sequence patterns consistent with conservation of 3-dimensional tertiary structure. We found patterns of putative xrRNA elements in a variety of viral 3 0 UTRs, all with the potential tertiary interactions observed in the 3-dimensional structure of the MVE xrRNA (Fig. 5) . This includes contacts which provide the ability to form the long-range L3-S4 pseudoknot and the S1-S3 interaction (base pairs and base triples) between the 5 0 end and the 3-way junction. Although the majority of these elements have not been directly tested for Xrn1 resistance, we predict that all are capable of this function and hence all should produce sfRNAs during infection by blocking Xrn1, using a similar 3-dimensional structure. Note that our analysis did not include sequences from more divergent arthropod-borne FVs that do not have obvious sequence similarity 27, 38 and whose Xrn1 resistance properties have not yet been extensively examined biochemically. We also did not include the recently described elements from the 5 0 ends of Hepatitis C Virus and Bovine Viral Diarrhea Virus (BVDV) as these appear to be structurally unrelated. 37 The analysis presented in Figure 5 shows that many of these FVs have two likely SL-type xrRNAs in their 3 0 UTR, while some have only one. This was first predicted by a survey of a smaller set of FVs, and more recently for a larger group. 19, 38, 39 As previously mentioned, the presence of multiple Xrn1 resistant structures in a FV 3 0 UTR appears to give rise to multiple sfRNA species in various cell types (Fig. 1A & B) , although this has only been examined in a few FVs. 19, 22, [33] [34] [35] [36] Multiple studies indicate that during WNV infection (which has 2 SL-type xrRNAs) the most abundant sfRNA is the largest (sfRNA1), with smaller species produced from a second SL-type xrRNA or dumbbell (DB) structures near the 3 0 end (Fig. 1C) . 19, 21, [33] [34] [35] [36] Preventing the production of sfRNA1 and sfRNA2 together during WNV infection leads to serious defects in replication, infection-induced pathogenicity and cytopathicity. 19 This appears to be due in part to disruption of the type I interferon response of the infected cells, 21 although other sfRNA-induced effects are also likely important. 27, 28 Interestingly, although WNV consistently produces multiple sfRNAs, sfRNA1 appears to be most important as mutations to the second xrRNA (WNVxrRNA2) to prevent sfRNA2 production have much more modest effects on viral growth and cytopathicity. 19, 33 In addition, when WNVxrRNA1 is mutated and sfRNA 1 production is lost, the amount of sfRNA2 does not increase to sfRNA1 levels 19, 33, 35, 36 , suggesting there are programmed levels of Xrn1 resistance in these tandem SL-type xrRNAs. It is not clear if these patterns are conserved across the diverse FVs, but these observations from WNV raise interesting new questions: Why do some FVs apparently have 2 xrRNAs, and some only one? What is the purpose of the second xrRNA (and smaller sfRNAs)? Are there patterns to this tandem xrRNA organization?
Although we cannot yet answer these questions, as a first step we compared characteristics of the sequences in Figure 5 . We measured the length of each xrRNA element in two ways: (1) from the first nucleotide predicted to form base pairs with the 3-way junction (the 5 0 end) to the last nucleotide of the predicted L3-S4 pseudoknot, and (2) from the 5 0 end to the last nucleotide in the predicted P4 stem (which we predict to be dispensable for halting Xrn1 in vitro with an xrRNA from DENV2). 35 Interestingly, an unexpected pattern emerged (Fig. 5C & D): 1. In the FV 3 0 UTRs that contain 2 putative xrRNAs, there is a clear trend; within each individual 3 0 UTR the length of the upstream (#1) xrRNA is longer than the downstream (#2) xrRNA. This was true for all FVs except DENV2. On average, the #2 xrRNAs are shorter overall. This is true whether or not the P4 stemloop is included in the length measurement. 2. The average length of putative xrRNAs in FV 3 0 UTRs that are predicted to have just one copy is roughly the same as the length of the first xrRNA (#1) in those predicted to contain two copies if the P4 stem-loop is not included.
If the P4 stem-loop is included in
the length measurement, the single xrRNAs were larger on average than either of the xrRNAs when two copies are present. Thus, in general, the P4/L4 stem-loop appears to have expanded in these single xrRNAs. Is there any biological or virological significance to these patterns? The answer is unknown, in large part because the measure of length of xrRNA is not a value we can yet relate to a specific characteristic that relates to function. Does length correlate with thermodynamic stability of secondary structures or tertiary interactions, with robustness of Xrn1 resistance, or with some other undiscovered feature? Have the longer xrRNAs evolved additional functionality unrelated to Xrn1 resistance? We also note that the potential length of the L3-S4 pseudoknot varies dramatically between xrRNAs -could this correlate with stability or activity? In addition, we do not know the significance of having one xrRNA versus 2; this further complicates efforts to understand the patterns. Clearly, more experiments are needed to understand how individual xrRNA structures operate within a larger context and if, within the highly conserved xrRNAs, there are subtle variations in stability, structure, or conformational dynamics that modulate function.
A model linking xrRNA tertiary structure, sfRNA production, and viral host adaptation
We do not yet understand how an individual xrRNA tertiary structure relates to the full architecture of a FV 3 0 UTR and to patterns of sfRNA production during infection, but recent observations from several papers lead to an interesting model. First, when we infected human cells with the Kunjin strain of WNV (WNV KUN ), the pattern of sfRNA production demonstrated that the first xrRNA (WNVxrRNA1) was very efficient in halting Xrn1, with most of the sfRNAs produced by this Wild-type (WT) virus and 2 mutants in which the S1-S3 tertiary interaction was abrogated in either the first xrRNA or second xrRNA are shown. These data were previously published. 35 (B) Secondary structure of the MVExrRNA2 as in Figure 2B . The regions of the second DENV xrRNA in which mutations accumulate during infection in mosquito cells are shaded green. These mutations would effectively abrogate tertiary interactions. (C) A model for how these mutations could alter sfRNA production as DENV cycles between human (left) and mosquito (right) hosts. "Strong" and "weak" refer to the efficiency of halting Xrn1, green shading shows where the second xrRNA builds up mutations, and hypothetical Northern blot analyses of noncoding sfRNA production are shown.
upstream xrRNA (Fig. 6A) . 35, 36 Consistent with previous studies, when this xrRNA was mutated to disrupt its tertiary structure, this sfRNA disappeared as expected, but levels of the second sfRNA that results from the action of the downstream xrRNA (WNVxrRNA2) increased only marginally. 19, 33, 35, 36 Thus, the downstream xrRNA is less efficient in its ability to halt Xrn1. More surprising, when WNVxrRNA2 was mutated to disrupt its tertiary structure the amount of sfRNA produced from WNVxrRNA1 also decreased, an effect noted previously but not yet explained. 19, 33, 35, 36 This suggests that the efficiency of sfRNA production from WNVxrRNA1 is coupled to the integrity of the tertiary structure of WNVxrRNA2 by some completely unknown mechanism (Fig. 6A) . To date, this coupling has only been examined or detected in WNV, clearly more exploration is needed to assess its significance.
The second observation comes from the recent work of Villordo et al.. 38 They showed that when Dengue infects mosquitos, the virus acquires mutations in the second of its 2 xrRNAs (DVxrRNA2) that revert when the mutant viruses are moved back to a mammalian host. We note that the mutations which accumulate during infection of mosquitos are specific to the parts of the xrRNA that form the two functionally critical tertiary interactions (Fig. 6B) . In other words, when DENV virus moves back and forth between mosquitos and humans, it seems to be modulating the tertiary structure of the second (downstream) of its 2 xrRNAs while maintaining the overall secondary structure and leaving xrRNA1 intact. What is the result of this? If the xrRNA coupling that we observed with WNV is also present in DENV (not yet tested), we predict these mutations result in a complete loss of sfRNA2 production and a decrease in the production of sfRNA1 during mosquito infection (Fig. 6C) . Upon movement to a human host, the virus can mutate to restore the tertiary interactions in xrRNA2, increasing sfRNA1 production. This model postulates that FVs with 2 xrRNAs maintain the potential for efficient sfRNA1 production by keeping xrRNA1 intact in both humans and mosquitos, but in mosquitos they "turn it down" by modulating specific tertiary structure interactions in xrRNA2 and the observed, as yet unexplained coupling effect. This would alter which sfRNAs are made and in what amount as the virus alternates between arthropod and mammalian cells (Fig. 6C) , and thus could alter the aforementioned sfRNA-dependent effects during infection. This model is in agreement with the conclusions of Villordo et al. 38 , who propose that mutation of one xrRNA and not the other helps confer robustness as the virus moves between hosts. Our model remains speculative, in part because we are merging observations from three viruses (MVE, WNV KUN , DENV). However, it provides a starting point for new experiments that may link overall 3
0 UTR architecture, RNA tertiary structure modulation, sfRNA production, coupling of tandem xrRNAs, and diverse sfRNA-dependent processes to the ability of these viruses to adapt to different hosts.
Conclusions
Analysis of the recent crystal structure of an xrRNA from MVE not only suggests a mechanism by which these xrRNAs halt the progression of a powerful cellular exonuclease, but also invites new hypotheses. This includes a model for how xrRNAs properly fold into their unusual structure within the context of the full viral RNA. The key tertiary structural elements appear to be well conserved across diverse mosquito-borne flaviviruses, but slight differences in these xrRNAs and their relationship to one another in the full viral 3 0 UTR may alter xrRNA function in unexplored ways. Modulation of tertiary structure during infection may regulate sfRNA production and we speculate that this is related to the viruses' ability to adapt to different hosts. Understanding these phenomena may be important in continuing efforts to create new vaccines and antiviral drugs.
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